Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
A penny at the moment ! Need dollars
I will certainly expect it
Lots of selling/buying … what’s the float?
Except O/S of WUHN <<<< MRES
MRES is a bloated pig billions
That’s what the sellers tell us …
“The float is Low” while they sell 10s of millions of shares
Is this what all this is about ?
Hurt us ALL to hurt this guy/company?
https://unicourt.com/case/nv-clad-camac-fund-lp-plaintiffs-vs-ramy-kamaneh-defendants-925618
This is a flop so far . FLOP
I speak learned truth .
Sure looks to me like AGE is owned by and will become Juvenescence … your thoughts??
Per last filing and many more , 13 Million dollar credit line, already used 10 million or 11 ?
Item 3.02 Unregistered Sales of Equity Securities.
In connection with AgeX’s June 6, 2022 draw of loan funds under the Secured Note (as defined in Item 2.03 of this Report), AgeX will issue to Juvenescence upon approval for listing by the NYSE American warrants to purchase 703,234 shares of AgeX common stock (“Warrants”) at an exercise price of $0.711 per share.
Item 9.01 - Financial Statements and Exhibits.
Exhibit Number Description
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AGEX THERAPEUTICS, INC.
Date: June 10, 2022 By: /s/ Andrea E. Park
Chief Financial Officer
You cannot eat mushrooms or drink high pH water and suddenly become alkaline ….
There are internal homeostasis measures for that control .
Bullshot promises and weak management?
Or … blame it on OTC web site delays, since February
No, still rudimentary 5 second effort front page up.
But has this “Our website is now live! We are currently running the final systems and API tests. The password will be removed as soon as everything is checked out.”
Very soon I heard !! $$$
It’s worth it !! Rigatoni especial
Nice pic of indoor healthy crop on Instagram GRYN
https://www.instagram.com/p/Ceol4TgpIQ-/?igshid=YmMyMTA2M2Y=
That’s pretty basic … hope it gets developed beyond this
It’s unknown at this point … more like widgets …. Could be coal or gold
Holding the bag here …
Plenty of shares to go around …
This is a Quiet Period for WUHN … Before a material event
What is standard practice and what is recommended?
Company disclosure policies in a quiet period depend on a number of factors. Which practices are most common? Typically, a company will opt to do one of the following:
Provide no formal or informal communications at all.
Provide limited communication and interaction with Wall Street by primarily:
Answering only fact-based inquiries
Imparting information only on overall long-term business and market trends
Making an announcement if it expects results to differ materially from earlier forecasts and answer questions about information already made public.
In the interests of fairness and to mitigate the risk of inadvertent disclosures of material information, the policy should reflect a company’s comfort level with the amount of disclosure it wants to provide to Wall Street and the investment community. It is important to strike a balance.
For example, going completely silent may not be in the best interests of small-cap companies that are thinly covered, or even for some larger companies.
If a company chooses to take investor and analyst calls during its quiet period, it needs to be clear and consistent in communicating the topics that are on and off-limits. It is also important that all designated spokespeople adopt the policy and remain consistent quarter over quarter.
Taken from:
https://www.irmagazine.com/reporting/six-commonly-asked-questions-and-answers-about-quiet-periods
LOL , I had lunch … twice
Still an unknown, MDCE with big potential
It better, lots of upside here in MONI
Shares dirt cheeep, and falling
Deja Vu … more waiting, crickets
Hope it runs GREEN !! MONEY
They will file late … doesn’t mean a thing
Added AGE here … the future looks BRIGHT $$
Someone kick mdce , see if it’s still alive
Any updates on this sleeping Dog? Mdce
Look at Facebook and Instagram , fields are planted and irrigation looks great
Lol !! MONI gonna fly
Hope you sold out, now we rise up ! MONI
Adding here WUHN … MMBS
Good day for cleaning up the sellers WUHN
One man’s trash is another man’s treasure . MONI could be a Diamond
LOL, he’s a busy and productive guy.
I like that enthusiasm , sell em if u got em
Insight … History of Magic Mushrooms
Hundreds of clinical trials have demonstrated the extraordinary potential of psychedelic compounds to treat post-traumatic stress disorder, anxiety, depression, eating disorders, obsessive-compulsive disorder, substance-use disorders, and other psychological ailments. Today, ketamine is legal and widely available in clinics across the country. MDMA is projected to become FDA-approved for the treatment of post-traumatic stress disorder as early as 2021. Psilocybin for treatment-resistant depression follows closely behind, with trials currently in Phase 2 of 3. Parallel decriminalization efforts have led to the legalization of psilocybin in Denver, Oakland, and Santa Cruz, with a ballot on the ticket in Oregon this November to legalize psilocybin for statewide use.
To investors, psychedelics are increasingly looking like a good bet. Last month, the psychedelic renaissance reached a new milestone when Compass Pathways, a London-based psilocybin research and therapy company, became the first psychedelic company to go public—receiving a post-IPO run-up valuation of $1.1 billion. Compass (which received seed investment from Peter Thiel’s Thiel Capital) was granted Breakthrough Therapy designation from the FDA for COMP360, a new method for the large-scale production of synthetic psilocybin. The company is currently conducting an FDA Phase 2b clinical trial of psilocybin therapy for treatment-resistant depression, with results expected in 2021.
A handful of new biotech companies have joined the race to develop psychedelic therapies and to patent synthetic variations of plant-based psychedelic compounds including psilocybin (the main compound from magic mushrooms), mescaline (found in the peyote and San Pedro cactus), and ibogaine (a psychoactive rainforest shrub native to West Africa). Other research companies are conducting trials on treatment applications for non-plant-derived psychedelics like MDMA and LSD. New York-based psychedelic biotech firm Mind Medicine broke into the market with a Phase 1 MDMA-LSD clinical trial and a Phase 2 study of LSD for the treatment of anxiety disorders. (The company applied to uplist to the Nasdaq in September.) And big pharma players like Johnson & Johson and AbbVie have wasted no time getting in on the game, developing their own ketamine derivatives.
In a mental healthcare industry that’s made little progress in novel treatments over the past 50 years—and whose current treatments are generally agreed to be woefully inadequate—the market potential of psychedelic medicine is clear. The psychedelic drug market is projected to grow at more than 16% annually and reach $6.85 billion by 2027, with a potential $100 billion market opportunity.
But this phenomenal growth hasn’t come without its growing pains. A rising movement within the psychedelic community is voicing concern that the emerging industry is poised to repeat colonial patterns that have appropriated Indigenous knowledge and led to the destruction of the habitats and communities from which these sacred plant medicines originate—while also making these new treatments inaccessible to many of the underserved populations who need them most.
https://neo.life/2020/10/inside-the-movement-to-decolonize-psychedelic-pharma/
My shares are locked up tight, trying to tempt sellers here is my game